Upgrade to SI Premium - Free Trial

After-Hours Stock Movers 12/03: (KBIO) (FIVE) (TRVN) Higher; (ZUMZ) (BKS) (COO) Lower (more...)

December 3, 2015 5:59 PM
KaloBios Pharma (NASDAQ: KBIO) 33.8% HIGHER; announced that it has signed an agreement to acquire a benznidazole program for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Special Reports

Next Articles